608 related articles for article (PubMed ID: 15966210)
1. Pseudomyxoma peritonei: a clinicopathologic analysis and follow-up of 21 patients.
Varona JF; Guerra JM; Salamanca J; Colina F; Lopez G; Morales M
Hepatogastroenterology; 2005; 52(63):812-6. PubMed ID: 15966210
[TBL] [Abstract][Full Text] [Related]
2. Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors.
Prayson RA; Hart WR; Petras RE
Am J Surg Pathol; 1994 Jun; 18(6):591-603. PubMed ID: 8179074
[TBL] [Abstract][Full Text] [Related]
3. Pseudomyxoma peritonei: a review of 23 cases.
Wertheim I; Fleischhacker D; McLachlin CM; Rice LW; Berkowitz RS; Goff BA
Obstet Gynecol; 1994 Jul; 84(1):17-21. PubMed ID: 8008316
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience of pseudomyxoma peritonei in Taiwan with emphasis on the treatment and survival.
Huang HC; Huang YS; Shyr YM; Yen SH; Chang FY; Lee SD
Hepatogastroenterology; 2002; 49(46):999-1001. PubMed ID: 12143263
[TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal hyperthermia in the management of pseudomyxoma peritonei.
Hsu KH; Chou CY; Chang YC
Hepatogastroenterology; 2007; 54(73):47-52. PubMed ID: 17419229
[TBL] [Abstract][Full Text] [Related]
6. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
McKenney JK; Soslow RA; Longacre TA
Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
[TBL] [Abstract][Full Text] [Related]
7. [An analysis of pathologic features and prognostic factors of 10 cases with pseudomyxoma peritonei].
Zhou X; Du X
Zhonghua Fu Chan Ke Za Zhi; 1995 Sep; 30(9):543-6. PubMed ID: 8556915
[TBL] [Abstract][Full Text] [Related]
8. [Pseudomyxoma peritonei; a rare tumour that can be treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
Smeenk RM; Verwaal VJ; Zoetmulder FA
Ned Tijdschr Geneeskd; 2007 Feb; 151(7):418-23. PubMed ID: 17343142
[TBL] [Abstract][Full Text] [Related]
9. Pseudomyxoma peritonei of appendiceal origin--a report of seven cases and a review of published reports.
Lang H; Jähne J; Flemming P; Meyer HJ; Pichlmayr R
Eur J Surg; 1995 May; 161(5):355-60. PubMed ID: 7662781
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and therapeutic considerations in pseudomyxoma peritonei].
Constantinoiu S; Chiru F; Mateş IN; Pop D; Cochior D; Bârlă R; Dinu D; Predescu D; Predescu V
Chirurgia (Bucur); 1998; 93(1):27-37. PubMed ID: 9567459
[TBL] [Abstract][Full Text] [Related]
11. Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation.
Yan H; Pestieau SR; Shmookler BM; Sugarbaker PH
Mod Pathol; 2001 Mar; 14(3):164-71. PubMed ID: 11266521
[TBL] [Abstract][Full Text] [Related]
12. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
[TBL] [Abstract][Full Text] [Related]
13. Quality of life after cytoreductive surgery plus early intraperitoneal postoperative chemotherapy for pseudomyxoma peritonei: a prospective study.
Jess P; Iversen LH; Nielsen MB; Hansen F; Laurberg S; Rasmussen PC
Dis Colon Rectum; 2008 Jun; 51(6):868-74. PubMed ID: 18297361
[TBL] [Abstract][Full Text] [Related]
14. Pseudomyxoma Peritonei arising from a mucinous borderline ovarian tumour: Case report and literature review.
Saluja M; Kenwright DN; Keating JP
Aust N Z J Obstet Gynaecol; 2010 Aug; 50(4):399-403. PubMed ID: 20716272
[No Abstract] [Full Text] [Related]
15. Pseudomyxoma peritonei. Histologic predictors of patient survival.
Costa MJ
Arch Pathol Lab Med; 1994 Dec; 118(12):1215-9. PubMed ID: 7979917
[TBL] [Abstract][Full Text] [Related]
16. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Smeenk RM; Verwaal VJ; Antonini N; Zoetmulder FA
Ann Surg; 2007 Jan; 245(1):104-9. PubMed ID: 17197972
[TBL] [Abstract][Full Text] [Related]
17. [Pseudomyxoma peritonei treated with complete resection and immediate intraperitoneal chemotherapy].
Elias D; Laurent S; Antoun S; Duvillard P; Ducreux M; Pocard M; Lasser P
Gastroenterol Clin Biol; 2003 Apr; 27(4):407-12. PubMed ID: 12759682
[TBL] [Abstract][Full Text] [Related]
18. MUC2 is a molecular marker for pseudomyxoma peritonei.
O'Connell JT; Hacker CM; Barsky SH
Mod Pathol; 2002 Sep; 15(9):958-72. PubMed ID: 12218214
[TBL] [Abstract][Full Text] [Related]
19. Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study.
Loungnarath R; Causeret S; Bossard N; Faheez M; Sayag-Beaujard AC; Brigand C; Gilly F; Glehen O
Dis Colon Rectum; 2005 Jul; 48(7):1372-9. PubMed ID: 15909071
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of complete cytoreductive surgery and two intraperitoneal chemotherapy techniques in Pseudomyxoma peritonei.
Sørensen O; Flatmark K; Reed W; Wiig JN; Dueland S; Giercksky KE; Larsen SG
Eur J Surg Oncol; 2012 Oct; 38(10):969-76. PubMed ID: 22763244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
